- Page 1 and 2:
aiv infeqcia/SidsiT avadmyofTa mkur
- Page 3 and 4:
sarCevi klinikuri saxelmZRvanelo-re
- Page 5 and 6:
3.2.2.cxeleba aiv inficirebulebSi 3
- Page 7 and 8:
aiv infeqcia/Sidsis fonze ganviTare
- Page 9 and 10:
done mtkicebulebis siZlieris done (
- Page 11 and 12:
1.daavadebis definicia Sidsi abrevi
- Page 13 and 14:
Sidsi registrirebulia msoflios 216
- Page 15 and 16:
egistrirebul SemTxveevaTa 79% saqar
- Page 17 and 18:
adamianis imunodeficitis virusis sa
- Page 19 and 20:
aiv rnm-is koncentracia plazmaSi mk
- Page 21 and 22:
SeuZlebelia da gadamwyveti misi dia
- Page 23 and 24:
persistuli generalizebuli limfadeno
- Page 25 and 26:
signalis amplifikacia komplementuri
- Page 27 and 28:
• vizitamde rezistentobis testis
- Page 29 and 30:
• adamianis papilomavirusi (maxvi
- Page 31 and 32:
etinitis identifikaciisTvis, rodesa
- Page 33 and 34:
cxrili 8 rekomendaciebi arT dawyebi
- Page 35 and 36:
arv medikamentebi arseboben Semdegi
- Page 37 and 38:
aCveneben, rom pirveladi rezistento
- Page 39 and 40:
- tabletebis Cveneba pacientisTvis
- Page 41 and 42:
- aqedan gamomdinare, nrti+anrti re
- Page 43 and 44:
igulisxmeba im medikamentebis kombi
- Page 45 and 46:
X (arv): testebi, romlebic unda Cat
- Page 47 and 48:
maRali mgrZnobeloba abakaviri (ABC
- Page 49 and 50:
transaminazebis elevacia anrti (all
- Page 51 and 52:
ARV toqsiuroba menejmenti nefrotoqs
- Page 53 and 54:
xSiri oportonistuli infeqciebia, ma
- Page 55 and 56:
cxrilebis wakiTxvis magaliTi 1. cxr
- Page 57 and 58:
damateba2. jandacvis msoflio organi
- Page 59 and 60:
damateba 4. ZiriTadi informacia ant
- Page 62 and 63:
damateba 5. mkurnalobis reJimis dac
- Page 64 and 65:
saerTaSoriso saxeli stavudini (d4T)
- Page 66 and 67:
mcire mutacia muSaobs kombinaciaSi.
- Page 68 and 69:
25. Phillips AN et al. Viral load o
- Page 70 and 71:
Suppl 2:S171-176. 73. Altice FL, Mo
- Page 72 and 73:
122. Koval CE et al. Immune reconst
- Page 74 and 75:
kandidozi dRe yovel dRe - ko-trimoq
- Page 76 and 77:
karcinoma (ara SidsTan perikardiuli
- Page 78 and 79:
o cxeleba o wonaSi kleba o Ramis of
- Page 80 and 81:
indikatorebi filtvis darRveuli funq
- Page 82 and 83:
o yvelaze xSirad viTardeba diarea,
- Page 84 and 85:
o glukokortikoidebis sistematiuri m
- Page 86 and 87:
100 mg/dReSi meore rigis sqemebi am
- Page 88 and 89:
o eqspoziciis Sedegad daavadebis ga
- Page 90 and 91:
o remisiis miRweva Zalian Znelia da
- Page 92 and 93:
qimioTerapiiT (mag : B-ALL reJimi)
- Page 94 and 95:
• imunodeficitis mqone pacientebS
- Page 96 and 97:
an famcikloviri 500 mg 3-jer dReSi
- Page 98 and 99:
• berkitis-tipis limfoma; • naz
- Page 100 and 101:
3.2.2. cxeleba aiv inficirebulebSi
- Page 102 and 103:
afTozuri wylulebi stomatiti qeiliti
- Page 104 and 105:
ganmavlobaSi 2 Tvis manZilze (xelis
- Page 106 and 107:
o gamonayari warmodgenilia mravlobi
- Page 108 and 109:
20. Chen XM et al. Cryptosporidiosi
- Page 110 and 111:
Tavi IV. aiv infeqcia/SidsiT daavad
- Page 112 and 113:
inficirebul bavSvebSi (ramdenadac a
- Page 114 and 115:
8 igulisxmeba piri, romelsac aReniS
- Page 116 and 117:
4.3. daxocili da inaqtivirebuli vaq
- Page 118 and 119:
kerebSi A hepatiti erTeuli an mcire
- Page 120 and 121:
13 riski maRalia staJirebis periodS
- Page 122 and 123: ganmavlobaSi, xolo SedarebiT ufro s
- Page 124 and 125: 4.8. tkipismieri encefalitis vaqcin
- Page 126 and 127: CvenebebiTa da doziT, rogorc imunok
- Page 128 and 129: 4.11.2.3. cofis sawinaaRmdego imuno
- Page 130 and 131: ekomendebulia: vaqcina rekomendebul
- Page 132 and 133: 8. United States Centers for Diseas
- Page 134 and 135: aiv infeqcia/Sidsis antiretrovirusu
- Page 136 and 137: 5. mkurnaloba a) rekomendebuli pirv
- Page 138 and 139: aiv infeqcia/SidsiT daavadebuli bav
- Page 140 and 141: joxiseburi TiTebi. Tumca wlebis man
- Page 142 and 143: * saWiroa arv preparatebis bavSvebi
- Page 144 and 145: laboratoriuli monacemebis kontroli
- Page 146 and 147: Tirkmlis funqciuri sinjebi, gulmker
- Page 148 and 149: aiv infeqcia/Sidsis fonze ganviTare
- Page 150 and 151: aiv infeqcia/Sidsis fonze ganviTare
- Page 152 and 153: 6. reabilitacia da dakvirveba monit
- Page 154 and 155: kandidozuri ezofagitis SemTxvevebSi
- Page 156 and 157: aiv infeqcia/Sidsis fonze ganviTare
- Page 158 and 159: aiv infeqcia/Sidsis fonze ganviTare
- Page 160 and 161: aiv infeqcia/Sidsis fonze ganviTare
- Page 162 and 163: aiv infeqcia/Sidsis fonze ganviTare
- Page 164 and 165: aiv infeqcia/Sidsis fonze ganviTare
- Page 166 and 167: aiv infeqcia/Sidsis fonze ganviTare
- Page 168 and 169: martivi herpesvirusuli infeqciis mZ
- Page 170 and 171: meTodiT, sisxlis saerTo analizi, Rv
- Page 174 and 175: aiv infeqcia/Sidsis fonze ganviTare
- Page 176 and 177: aiv infeqcia/Sidsis fonze ganviTare
- Page 178 and 179: aiv infeqcia/Sidsis fonze ganviTare
- Page 180 and 181: aiv infeqcia/Sidsis fonze ganviTare
- Page 182 and 183: aiv infeqcia/Sidsis fonze ganviTare
- Page 184 and 185: aiv infeqcia/Sidsis fonze ganviTare
- Page 186 and 187: aiv infeqcia/SidsiT avadmyofebSi B
- Page 188 and 189: dinamikaSi dakvirveba CD4≥500/mm
- Page 190 and 191: HBV mkurnalobis efeqturoba HBeAg (+
- Page 192 and 193: ) gamomricxavi - aiv infeqcia/Sidsi
- Page 194 and 195: pegilirebuli interferonis da ribavi
- Page 196 and 197: i CD4 X X X X X X X X X TSH X X X H
- Page 198 and 199: )gamomricxavi - aiv infeqcia/Sidsis
- Page 200 and 201: pirveli rigis antituberkulozuri med
- Page 202: testebi: • sisxlis saerTo analizi